**Core Concept**
The question is testing the pharmacological principle of neuromuscular blocking agents, specifically the interaction between succinylcholine (scoline) and other substances. Succinylcholine is a depolarizing neuromuscular blocker that acts on the nicotinic acetylcholine receptor.

**Why the Correct Answer is Right**
Although the correct answer option is missing, typically, the action of succinylcholine is potentiated by substances that inhibit the enzyme responsible for its breakdown, such as anticholinesterases, or by altering the pharmacokinetics of succinylcholine.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's challenging to provide a detailed explanation, but generally, options that do not affect the nicotinic acetylcholine receptor or the breakdown of succinylcholine would be incorrect.
**Option B:** Similarly, without the specific option, it's hard to comment, but any option that does not enhance the effect of succinylcholine at the neuromuscular junction would be wrong.
**Option C:** This option would be incorrect if it does not influence the metabolism or the receptor interaction of succinylcholine.
**Option D:** Without knowing the option, any substance that does not potentiate the neuromuscular blocking effect of succinylcholine would be an incorrect choice.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that the effect of succinylcholine can be significantly altered by substances that affect its metabolism or the neuromuscular junction, highlighting the importance of understanding drug interactions in anesthesia.

**Correct Answer:** Correct Answer: D. Magnesium.